URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Lisa Demeter

Concepts (278)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
HIV-1
66
1995
536
11.540
Why?
HIV Infections
46
1995
579
7.680
Why?
Anti-HIV Agents
35
1996
172
7.500
Why?
HIV Reverse Transcriptase
23
1995
110
4.680
Why?
Reverse Transcriptase Inhibitors
25
1995
88
4.630
Why?
Virus Replication
21
1992
291
4.260
Why?
Drug Resistance, Viral
21
2003
66
4.220
Why?
HIV Protease Inhibitors
11
1997
57
3.050
Why?
Mutation
21
1995
1216
2.490
Why?
Drug Monitoring
6
2003
41
2.470
Why?
Acquired Immunodeficiency Syndrome
10
1995
193
2.220
Why?
RNA, Viral
26
1990
275
2.160
Why?
Zidovudine
14
1995
69
1.930
Why?
Indinavir
8
1997
18
1.890
Why?
Drug Resistance, Microbial
14
1997
120
1.600
Why?
Ribonuclease H
5
1999
74
1.370
Why?
Delavirdine
6
1997
14
1.350
Why?
HIV
6
2001
71
1.300
Why?
Viral Load
15
1997
135
1.260
Why?
Benzoxazines
7
2003
35
1.220
Why?
Lamivudine
5
1997
27
1.200
Why?
CD4 Lymphocyte Count
19
1995
148
1.170
Why?
DNA, Viral
12
1990
292
1.160
Why?
Microbial Sensitivity Tests
8
1995
170
1.150
Why?
Humans
76
1990
36274
0.980
Why?
Recombination, Genetic
2
2004
176
0.960
Why?
Antiretroviral Therapy, Highly Active
7
2003
61
0.950
Why?
HIV Protease
3
2004
22
0.890
Why?
Papillomaviridae
7
1990
137
0.880
Why?
Dideoxynucleosides
3
2003
15
0.840
Why?
RNA-Directed DNA Polymerase
2
1995
59
0.800
Why?
Drug Therapy, Combination
16
1995
382
0.800
Why?
Tumor Virus Infections
4
1992
61
0.740
Why?
Piperazines
4
1995
74
0.730
Why?
Adult
36
1990
11351
0.710
Why?
Oxazines
3
2003
29
0.690
Why?
Cell Line
11
1999
1585
0.680
Why?
Genes, Viral
4
1998
86
0.650
Why?
Didanosine
3
1995
21
0.650
Why?
Mutagenesis, Site-Directed
5
2000
290
0.630
Why?
Flow Cytometry
2
2006
603
0.590
Why?
Female
39
1990
19838
0.570
Why?
Male
33
1990
19675
0.540
Why?
Models, Biological
3
2006
1008
0.510
Why?
DNA Replication
1
2006
200
0.500
Why?
Gene Products, gag
1
2004
17
0.490
Why?
Genome, Viral
1
2004
37
0.480
Why?
Leukocytes, Mononuclear
2
1998
110
0.480
Why?
Genotype
10
1998
490
0.470
Why?
Antiviral Agents
4
1995
175
0.460
Why?
Sequence Analysis, DNA
3
1998
166
0.440
Why?
Treatment Outcome
10
1996
2615
0.420
Why?
Middle Aged
16
1993
9837
0.420
Why?
AIDS-Related Opportunistic Infections
1
2002
63
0.410
Why?
Base Sequence
7
1995
1683
0.400
Why?
Mutation, Missense
3
2010
87
0.390
Why?
Pneumonia, Pneumocystis
1
2002
119
0.390
Why?
Laboratories
2
1998
25
0.370
Why?
Phenotype
7
1997
763
0.370
Why?
Tyrosine
1
2001
132
0.370
Why?
HIV Envelope Protein gp120
1
2000
46
0.370
Why?
Cysteine
1
2001
155
0.360
Why?
Defective Viruses
1
1999
14
0.350
Why?
Cells, Cultured
8
1992
2479
0.340
Why?
Interferon-gamma
4
2000
348
0.330
Why?
Uterine Cervical Neoplasms
2
1992
125
0.320
Why?
Kinetics
4
1999
1391
0.320
Why?
Papillomavirus Infections
2
1994
49
0.310
Why?
Anti-Retroviral Agents
3
2003
22
0.290
Why?
Carcinoma in Situ
2
1992
41
0.290
Why?
Condylomata Acuminata
5
1990
51
0.280
Why?
Indoles
1
1997
101
0.270
Why?
Nelfinavir
3
2003
7
0.270
Why?
Reagent Kits, Diagnostic
2
2004
15
0.260
Why?
HIV Core Protein p24
3
1998
28
0.260
Why?
Carcinoma, Squamous Cell
2
1992
236
0.250
Why?
Papilloma
1
1994
13
0.240
Why?
Drug Administration Schedule
3
2009
366
0.240
Why?
Prevalence
3
1993
562
0.230
Why?
Clinical Trials as Topic
3
2000
671
0.230
Why?
Double-Blind Method
6
1990
992
0.230
Why?
Penile Neoplasms
1
1993
16
0.230
Why?
Keratinocytes
1
1994
106
0.220
Why?
Antigens, Neoplasm
1
1994
106
0.220
Why?
Codon
3
1998
70
0.220
Why?
Treatment Failure
4
2000
128
0.210
Why?
Point Mutation
2
1999
172
0.210
Why?
Receptors, Immunologic
1
1992
49
0.200
Why?
Molecular Sequence Data
4
1995
1988
0.200
Why?
Virus Cultivation
2
1992
30
0.190
Why?
HeLa Cells
2
1999
296
0.190
Why?
Computer Simulation
2
2008
302
0.190
Why?
Follow-Up Studies
4
1990
1855
0.190
Why?
CD8-Positive T-Lymphocytes
2
1997
224
0.190
Why?
5' Untranslated Regions
2
1999
22
0.180
Why?
Virology
1
2010
22
0.180
Why?
HIV Envelope Protein gp41
1
2010
4
0.180
Why?
Sensitivity and Specificity
4
2003
905
0.180
Why?
Virulence
1
2010
153
0.180
Why?
Virus Latency
1
2010
14
0.180
Why?
Nuclear Proteins
1
1994
335
0.180
Why?
Virion
1
2010
65
0.180
Why?
Pregnancy Complications, Infectious
3
1995
84
0.170
Why?
Linear Models
2
2006
237
0.170
Why?
Software
1
2010
125
0.170
Why?
Internet
1
2010
98
0.170
Why?
Polymerase Chain Reaction
5
1997
596
0.160
Why?
Virus Physiological Phenomena
1
2008
5
0.160
Why?
T-Lymphocytes
3
2001
550
0.160
Why?
CD4-Positive T-Lymphocytes
2
1997
303
0.160
Why?
Biometry
1
2008
43
0.160
Why?
Reproducibility of Results
3
1998
877
0.150
Why?
Antigens, Fungal
2
2002
34
0.150
Why?
Peptide Fragments
1
2010
282
0.150
Why?
Lymphocyte Count
2
1997
53
0.150
Why?
RNA, Transfer, Amino Acyl
2
2001
13
0.150
Why?
Mice, SCID
1
2007
172
0.150
Why?
Stavudine
2
1997
5
0.140
Why?
Cervical Intraepithelial Neoplasia
1
2006
26
0.140
Why?
Developing Countries
1
2006
41
0.140
Why?
RNA, Transfer, Lys
1
2006
11
0.140
Why?
Antigens, Thy-1
1
2006
60
0.140
Why?
Pregnancy
5
1995
1966
0.130
Why?
Mathematics
1
2006
149
0.130
Why?
Mice
3
1992
6111
0.130
Why?
Interferons
2
1996
48
0.130
Why?
Amino Acid Substitution
1
2006
124
0.130
Why?
Animals
4
1992
16093
0.130
Why?
Genes, Reporter
1
2006
208
0.130
Why?
Research Design
1
2008
336
0.130
Why?
T-Lymphocytes, Cytotoxic
1
2006
128
0.130
Why?
DNA Primers
1
2006
403
0.130
Why?
Nucleosides
1
2004
11
0.120
Why?
RNA, Messenger
1
1992
1863
0.120
Why?
Templates, Genetic
1
2004
74
0.120
Why?
Disease Progression
3
1997
521
0.120
Why?
Cercopithecus aethiops
1
2004
158
0.120
Why?
COS Cells
1
2004
160
0.120
Why?
Sequence Alignment
1
2004
191
0.120
Why?
Adenine
1
2003
45
0.110
Why?
Cloning, Molecular
1
2004
494
0.110
Why?
Retrospective Studies
4
1995
2267
0.110
Why?
Mutagenesis
2
1999
130
0.110
Why?
Oncogene Proteins, Viral
2
1992
47
0.110
Why?
Aged
4
1999
7269
0.110
Why?
DNA, Fungal
1
2002
84
0.100
Why?
Proviruses
2
1997
9
0.100
Why?
Pneumocystis
1
2002
101
0.100
Why?
Clinical Protocols
1
2001
106
0.100
Why?
Vaccines, DNA
1
2001
22
0.100
Why?
Papillomavirus Vaccines
1
2001
21
0.100
Why?
3' Untranslated Regions
1
2001
32
0.100
Why?
Adenosine
1
2001
86
0.100
Why?
Hydrolysis
1
2001
141
0.100
Why?
Heteroduplex Analysis
1
2000
3
0.090
Why?
Dehydroepiandrosterone Sulfate
1
2000
7
0.090
Why?
Sequence Analysis
1
2000
26
0.090
Why?
Practice Guidelines as Topic
1
2003
302
0.090
Why?
Viral Vaccines
1
2001
109
0.090
Why?
Guidelines as Topic
1
2001
89
0.090
Why?
Autonomic Nervous System
1
2000
68
0.090
Why?
Predictive Value of Tests
1
2002
606
0.090
Why?
Evolution, Molecular
1
2000
67
0.090
Why?
Logistic Models
1
2001
611
0.080
Why?
Gene Amplification
1
1998
28
0.080
Why?
Drug Eruptions
1
1998
27
0.080
Why?
Drug Resistance
2
1995
102
0.080
Why?
Specimen Handling
2
2006
71
0.080
Why?
Interferon-alpha
2
1990
83
0.070
Why?
Immunotherapy
1
1997
86
0.070
Why?
Cell Proliferation
2
2008
515
0.070
Why?
Biopsy
1
1996
362
0.060
Why?
Infectious Disease Transmission, Vertical
1
1995
47
0.060
Why?
Cohort Studies
1
1998
969
0.060
Why?
Genital Neoplasms, Male
1
1994
15
0.060
Why?
Genital Neoplasms, Female
1
1994
33
0.060
Why?
Laryngeal Neoplasms
1
1994
19
0.060
Why?
Proliferating Cell Nuclear Antigen
1
1994
48
0.060
Why?
Immunoenzyme Techniques
1
1994
220
0.060
Why?
Virus Integration
1
1993
23
0.060
Why?
Blotting, Southern
1
1993
99
0.060
Why?
Regression Analysis
3
1990
527
0.060
Why?
In Situ Hybridization
1
1994
323
0.060
Why?
Area Under Curve
2
2000
63
0.060
Why?
Vaginal Smears
2
1999
69
0.060
Why?
Receptors, Laminin
1
1992
7
0.050
Why?
Warts
1
1992
23
0.050
Why?
Nucleic Acid Hybridization
1
1992
175
0.050
Why?
Pyridazines
1
2011
7
0.050
Why?
Nevirapine
1
2011
8
0.050
Why?
Patient Selection
2
2003
212
0.050
Why?
Neoplasm Invasiveness
1
1992
155
0.050
Why?
Blotting, Northern
1
1992
304
0.050
Why?
RNA, Complementary
1
2010
13
0.050
Why?
Antigens, Bacterial
1
2011
92
0.050
Why?
Antigens, Viral
1
2011
149
0.050
Why?
Interferon Type I
1
1990
37
0.050
Why?
Calibration
1
2010
44
0.050
Why?
Ribonuclease H, Human Immunodeficiency Virus
1
2010
2
0.050
Why?
Drug Resistance, Multiple, Viral
1
2010
6
0.050
Why?
Quality Control
1
2010
70
0.050
Why?
Selection, Genetic
1
2010
14
0.050
Why?
Placebos
1
2010
178
0.050
Why?
Viremia
1
2009
26
0.040
Why?
Cell Division
1
1992
762
0.040
Why?
Statistics, Nonparametric
1
2010
262
0.040
Why?
Adolescent
2
1993
4766
0.040
Why?
New York
2
1999
1305
0.040
Why?
Least-Squares Analysis
1
2008
29
0.040
Why?
Nonlinear Dynamics
1
2008
35
0.040
Why?
Monte Carlo Method
1
2008
58
0.040
Why?
Acute Disease
1
2009
586
0.040
Why?
Ritonavir
1
2007
14
0.040
Why?
Lopinavir
1
2007
16
0.040
Why?
Safety
2
1995
101
0.040
Why?
Developed Countries
1
2006
5
0.040
Why?
Pyrimidinones
1
2007
21
0.040
Why?
Infant, Newborn
2
1995
1844
0.040
Why?
Maternal-Fetal Exchange
1
2006
141
0.030
Why?
Young Adult
1
2010
1059
0.030
Why?
Herpesvirus 4, Human
1
2006
62
0.030
Why?
Cytomegalovirus
1
2006
79
0.030
Why?
Fibroblasts
2
1992
534
0.030
Why?
Enzyme-Linked Immunosorbent Assay
1
2006
462
0.030
Why?
Prospective Studies
1
2009
1689
0.030
Why?
Algorithms
1
2008
541
0.030
Why?
Pharmacogenetics
1
2003
10
0.030
Why?
Vesicular stomatitis Indiana virus
1
2003
12
0.030
Why?
Peptides
1
2006
285
0.030
Why?
Protease Inhibitors
1
2003
40
0.030
Why?
HIV Seropositivity
1
2003
34
0.030
Why?
Chronic Disease
1
2006
522
0.030
Why?
Health Planning Guidelines
1
2003
23
0.030
Why?
Transcription, Genetic
2
1992
812
0.030
Why?
HLA Antigens
1
2003
99
0.030
Why?
Patient Compliance
1
2003
174
0.030
Why?
Methylation
1
2001
51
0.030
Why?
Recurrence
2
1990
691
0.020
Why?
Interleukin-5
1
2001
42
0.020
Why?
Capsid Proteins
1
2001
32
0.020
Why?
beta 2-Microglobulin
1
2000
19
0.020
Why?
Species Specificity
1
2001
341
0.020
Why?
Th1 Cells
1
2000
70
0.020
Why?
Polyneuropathies
1
2000
42
0.020
Why?
Th2 Cells
1
2000
94
0.020
Why?
Respiration
1
2000
181
0.020
Why?
Interleukin-4
1
2000
163
0.020
Why?
Outpatient Clinics, Hospital
1
1999
43
0.020
Why?
Europe
1
1999
80
0.020
Why?
Cervix Uteri
1
1999
65
0.020
Why?
Risk Assessment
1
2003
884
0.020
Why?
Lymphocyte Activation
1
2001
410
0.020
Why?
Sex Characteristics
1
2000
138
0.020
Why?
World Health
1
1999
63
0.020
Why?
Antibodies, Viral
1
2001
472
0.020
Why?
Transfection
1
2001
859
0.020
Why?
Heart Rate
1
2000
461
0.020
Why?
Cognition Disorders
1
2000
286
0.020
Why?
Vaccines, Synthetic
1
1997
90
0.020
Why?
Cryosurgery
1
1996
38
0.020
Why?
Cross-Sectional Studies
1
1999
654
0.020
Why?
Dose-Response Relationship, Drug
1
1999
1117
0.020
Why?
United States
1
2003
2688
0.020
Why?
Longitudinal Studies
1
1997
395
0.020
Why?
Combined Modality Therapy
1
1996
486
0.020
Why?
Prognosis
1
1996
1083
0.010
Why?
3T3 Cells
1
1992
76
0.010
Why?
Epithelium
1
1992
228
0.010
Why?
Bisexuality
1
1990
11
0.010
Why?
Homosexuality
1
1990
23
0.010
Why?
Injections, Subcutaneous
1
1990
90
0.010
Why?
Epithelial Cells
1
1992
327
0.010
Why?
Infant
1
1995
2278
0.010
Why?
Risk Factors
1
1996
2345
0.010
Why?
Sex Factors
1
1990
597
0.010
Why?
Recombinant Proteins
1
1990
723
0.010
Why?
Time Factors
1
1995
3182
0.010
Why?
Cell Differentiation
1
1992
1093
0.010
Why?

Visualizations


Demeter's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department